Stay updated on REL-1017 Monotherapy for MDD Clinical Trial
Sign up to get notified when there's something new on the REL-1017 Monotherapy for MDD Clinical Trial page.

Latest updates to the REL-1017 Monotherapy for MDD Clinical Trial page
- Check4 days agoChange DetectedThe latest version updates the study status and related sections in the record history. It includes changes to Eligibility, Outcome Measures, and Adverse Events reflecting new information about the trial.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check33 days agoChange DetectedNew operating-status notice and version update to v3.2.0; previous v3.1.0 version tag removed.SummaryDifference12%

- Check40 days agoChange DetectedVersion update: from v3.0.2 to v3.1.0. The change is limited to the revision label; no core content or critical data appears to be altered.SummaryDifference0.3%

- Check54 days agoChange DetectedUpdated page revision from v3.0.1 to v3.0.2, indicating a minor update. The 'Back to Top' element was removed, a small UI change with no impact on core content.SummaryDifference0.7%

- Check61 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1.SummaryDifference0.7%

- Check69 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location details, while removing specific state, country, and city information.SummaryDifference14%

Stay in the know with updates to REL-1017 Monotherapy for MDD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the REL-1017 Monotherapy for MDD Clinical Trial page.